BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7756739)

  • 1. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased synthesis and delayed processing of sulfated glycoproteins by cells from human polycystic kidneys.
    Carone FA; Jin H; Nakamura S; Kanwar YS
    Lab Invest; 1993 Apr; 68(4):413-8. PubMed ID: 8479149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell polarity in human renal cystic disease.
    Carone FA; Nakamura S; Caputo M; Bacallao R; Nelson WJ; Kanwar YS
    Lab Invest; 1994 May; 70(5):648-55. PubMed ID: 8196361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia.
    Wilson PD; Hreniuk D; Gabow PA
    J Cell Physiol; 1992 Feb; 150(2):360-9. PubMed ID: 1734038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
    Sessa A; Ghiggeri GM; Turco AE
    J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic kidney disease: new understanding in the pathogenesis.
    Wilson PD
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of progression in autosomal dominant polycystic kidney disease.
    Grantham JJ
    Kidney Int Suppl; 1997 Dec; 63():S93-7. PubMed ID: 9407432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene profiling of polycystic kidneys.
    Schieren G; Rumberger B; Klein M; Kreutz C; Wilpert J; Geyer M; Faller D; Timmer J; Quack I; Rump LC; Walz G; Donauer J
    Nephrol Dial Transplant; 2006 Jul; 21(7):1816-24. PubMed ID: 16520345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
    Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
    J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic kidney disease: huge kidneys, huge problems, huge progress.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 1997; 108():165-70; discussion 170-2. PubMed ID: 9108675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of autosomal dominant polycystic kidney disease.
    Watnick T; Germino GG
    Semin Nephrol; 1999 Jul; 19(4):327-43. PubMed ID: 10435671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure and function of the experimental polycystic kidney induced by diphenylthiazole with special reference to renal micropuncture study].
    Kubota K
    Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):859-69. PubMed ID: 1484405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal recessive polycystic kidney disease in a murine model. A gross and microscopic description.
    Gattone VH; Calvet JP; Cowley BD; Evan AP; Shaver TS; Helmstadter K; Grantham JJ
    Lab Invest; 1988 Aug; 59(2):231-8. PubMed ID: 3404974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apico-basal polarity in polycystic kidney disease epithelia.
    Wilson PD
    Biochim Biophys Acta; 2011 Oct; 1812(10):1239-48. PubMed ID: 21658447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and ontogenesis of tenascin in normal and cystic human fetal kidneys.
    Daïkha-Dahmane F; Dommergues M; Narcy F; Lacoste M; Gubler MC
    Lab Invest; 1995 Oct; 73(4):547-57. PubMed ID: 7474927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular pathophysiology of cystic kidney disease: insight into future therapies.
    Avner ED; Woychik RP; Dell KM; Sweeney WE
    Int J Dev Biol; 1999; 43(5):457-61. PubMed ID: 10535324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse.
    Yoo KH; Kim YN; Lee MJ; Seong JK; Park JH
    Proteomics; 2009 Aug; 9(15):3824-32. PubMed ID: 19637234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of polycystic kidney disease.
    Calvet JP
    J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cystogenesis: the search for drugs antagonizing cyst development.
    Ibraghimov-Beskrovnaya O; Bukanov NO
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S109-14. PubMed ID: 17373209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.